ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,319 Cr | ₹1,012 Cr | ₹1,213 Cr | ₹893 Cr | ₹948 Cr |
What is the latest Cash Flow from Operating Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,319 Cr |
| Mar2025 | ₹1,012 Cr |
| Mar2024 | ₹1,213 Cr |
| Mar2023 | ₹893 Cr |
| Mar2022 | ₹948 Cr |
How is Cash Flow from Operating Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,319 Cr | 30.38 | |
| Mar2025 | ₹1,012 Cr | -16.57 | |
| Mar2024 | ₹1,213 Cr | 35.75 | |
| Mar2023 | ₹893 Cr | -5.73 | |
| Mar2022 | ₹948 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,640.7 Cr | -2.6% | -8.7% | -21.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -2.6% |
-8.7% |
-21.5% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses